MOSCOW (MRC) -- Solvay Polyamide & Intermediates is investing in the adipic acid production line at its industrial plant in Chalampe, France, according to the company's press release.
The intended capital investment aims at reinforcing cost leadership by significantly reducing the site’s energy consumption.
The investment will result in a further improvement of the adipic acid manufacturing process contributing to Polyamide & Intermediates’ strategic positioning. It demonstrates the group’s commitment to operational excellence through energy efficiency programs and carbon footprint reduction initiatives.
"This new process will result in an 8MW reduction of energy consumption per year as well as 11,000-ton reduction in CO2 emissions," points out Christophe Bertrand, Industrial Director of Polyamide & Intermediates. The intervention, which will require a complete shutdown of the manufacturing process, will take place in the fourth quarter of 2013 and will last about one month.
This project is part of Solvay Group’s initiative to achieve a EUR100M REBITDA improvement of its polyamide business by 2014. It marks the first major investment in productivity and efficiency, targeting business leadership and profitability as well as Sustainable development in line with the Group Solvay Way target.
We remind that, as MRC informed previously, last year Solvay and Russian petrochemical company Sibur signed an agreement to establish Ruspav, a 50/50 joint venture for the production of surfactants and oilfield process chemicals in Dzerzhinsk, Russia. Ruspav will be located near SIBUR's petrochemicals operations, 400km east of Moscow, and is expected to be operational in 2015.
SOLVAY Polyamide & Intermediates, headquartered in Brussels, is a major global producer of polyamide 6.6 intermediates and polymers focused on being a reliable partner to customers worldwide. P&I develops and provides polyamide 66 intermediates from HMD, adipic acid, nylon salt down to polymers through its 7 industrial plants, 3 research & development centers and 7 sales offices in the world. Thanks to its fully integrated value chain, P&I is a major player on engineering plastics, textile, industrial yarns and performance fibers markets with its long lasting polymer range Stabamid and its new intermediates product offer: Rhodiamine and Rhodiacid. In 2012 the company generated EUR12.4 billion in net sales.
MRC